China SXT Pharmaceuticals (SXTC) Long-Term Deferred Tax (2018 - 2021)

China SXT Pharmaceuticals' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $321444.0 for Q1 2021.

• In Q1 2021, Long-Term Deferred Tax rose 184.87% year-over-year to $321444.0; the TTM figure through Mar 2021 stood at $321444.0 (up 184.87% YoY), while the FY2021 annual figure was $321444.0, up 184.87% from the prior year.
• Long-Term Deferred Tax was $321444.0 for Q1 2021 at China SXT Pharmaceuticals, up from $23367.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $321444.0 in Q1 2021 to a low of $6174.0 in Q1 2018.
• Historically, Long-Term Deferred Tax has averaged $81667.8 across 4 years, with a median of $18435.5 in 2019.
• Biggest YoY gain for Long-Term Deferred Tax was 735.6% in 2020; the steepest drop was 84.3% in 2020.
• A 4-year view of Long-Term Deferred Tax shows it stood at $6174.0 in 2018, then soared by 105.36% to $12679.0 in 2019, then soared by 84.3% to $23367.0 in 2020, then jumped by 1275.63% to $321444.0 in 2021.
• The last three Long-Term Deferred Tax figures came in at $321444.0 (Q1 2021), $23367.0 (Q3 2020), and $112839.0 (Q1 2020), per Business Quant data.